FDA clears 1st blood test for Alzheimer’s in primary care / Beckers

Ella Jeffries / beckershospitalreview - The first FDA-cleared blood test to assess Alzheimer’s disease in primary care is now available for patients age 55 and older with symptoms of cognitive decline. The test aims to help clinicians rule out Alzheimer’s by identifying individuals unlikely to …

#healthcare #publichealth #governmentpolicy #biotech #fda

A possible Alzheimer's biomarker? Why REST protein levels are drawing attention

20 days / medicalxpress

J&J pauses patient recruitment in mid-stage trial of AC Immune’s Alzheimer’s drug

20 days / endpoints / Elizabeth Cairns

Blood test 'clocks' can predict when Alzheimer's symptoms will start

20 days / medicalxpress

Viagra and shingles vaccine show surprising promise against Alzheimer’s

21 days / sciencedaily

Paragon's new biotech Korsana tackles Alzheimer's like Roche

21 days / endpoints / Kyle LaHucik

Air pollution may directly contribute to Alzheimer's disease

21 days / medicalxpress

The good side of a side effect: Brain swelling during Alzheimer's treatment may signal strong response

21 days / medicalxpress

Connecting the dots between cause-effect events in Alzheimer's disease

22 days / medicalxpress

Alzheimer's gene boosts seizures, but pathway can be targeted, study finds

22 days / medicalxpress

Senescent astrocytes discovered in Alzheimer's brains point to new treatment targets

22 days / medicalxpress

Hearing loss and cognitive decline in presbycusis may be linked via neural activity fluctuations, cell death

22 days / medicalxpress

Neurodegenerative diseases need more mechanism-informed trials

23 days / nature

A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders

23 days / nature / Katharina Bolsewig

Your morning coffee might protect your brain as you age. Here's the sweet spot

24 days / medicalxpress

Menopause, hormones and the brain: How hormone therapy could help protect against Alzheimer's

25 days / medicalxpress

Blood-based tests show strong promise for dementia diagnosis—but population diversity matters

25 days / medicalxpress

FDA clears 1st blood test for Alzheimer’s in primary care

28 days / beckershospitalreview / Ella Jeffries

Capillary blood sampling for detecting biomarkers of Alzheimer’s disease

28 days / nature

Saturday, February 14, 2026, 4:21 am / permalink 19180 / 18 stories in 25 days



Related Stories



Related Tags


Healthcare

Judge orders Leapfrog to remove safety grades for five Florida hospitals (21 hrs)

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis (40 hrs)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

more #healthcare


Public Health

Judge orders Leapfrog to remove safety grades for five Florida hospitals (21 hrs)

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis (40 hrs)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

more #publichealth


Government Policy

Judge orders Leapfrog to remove safety grades for five Florida hospitals (21 hrs)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

Covid inquiry final hearings spotlight bereaved families and costs (4 days)

more #governmentpolicy


StackHealth Time Machine



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.